We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PTC
PTC
$15.8B
| $25M | 0.05% |
301,232
+85,735
| +40% | +$7.53M |
|
327
Best Buy
BBY
$18.2B
| $24.9M | 0.05% |
469,914
-13,605
| -3% | -$889K |
|
328
MSCI
MSCI
$41.6B
| $24.8M | 0.05% |
168,132
-4,956
| -3% | -$754K |
|
329
Steris
STE
$22.3B
| $24.8M | 0.05% |
231,691
+73,222
| +46% | +$8.18M |
|
330
Citizens Financial Group
CFG
$30.3B
| $24.7M | 0.05% |
832,221
-50,401
| -6% | -$1.77M |
|
|
WP
331
DELISTED
Worldpay, Inc.
WP
| $24.7M | 0.05% |
322,638
+1,224
| +0.4% | +$106K |
|
332
West Pharmaceutical
WST
$24B
| $24.4M | 0.05% |
249,152
+63,381
| +34% | +$6.88M |
|
333
MarketAxess Holdings
MKTX
$5.71B
| $24.4M | 0.05% |
115,466
+27,151
| +31% | +$5.62M |
|
|
334
Diamondback Energy
FANG
$57.1B
| $24.3M | 0.05% |
262,348
+170,136
| +185% | +$19M |
|
335
Darden Restaurants
DRI
$23.3B
| $24.2M | 0.05% |
242,375
-2,580
| -1% | -$276K |
|
336
Arthur J. Gallagher & Co
AJG
$64.1B
| $24.1M | 0.05% |
326,960
+68
| +0% | +$5.08K |
|
|
MRO
337
DELISTED
Marathon Oil Corporation
MRO
| $24M | 0.05% |
1,674,618
+43,364
| +3% | +$774K |
|
338
Synopsys
SNPS
$74.4B
| $24M | 0.05% |
284,413
-1,346
| -0.5% | -$120K |
|
339
C.H. Robinson
CHRW
$17.4B
| $23.9M | 0.05% |
284,260
-15,474
| -5% | -$1.38M |
|
340
Expedia Group
EXPE
$35.4B
| $23.9M | 0.05% |
211,987
-8,768
| -4% | -$1.05M |
|
|
LLL
341
DELISTED
L3 Technologies, Inc.
LLL
| $23.8M | 0.05% |
137,263
+5,516
| +4% | +$1.06M |
|
342
Cardinal Health
CAH
$53.9B
| $23.8M | 0.05% |
533,249
-5,418
| -1% | -$282K |
|
343
Xylem
XYL
$27.3B
| $23.8M | 0.05% |
356,447
-1,653
| -0.5% | -$114K |
|
344
Host Hotels & Resorts
HST
$17.2B
| $23.7M | 0.05% |
1,424,409
+7,724
| +0.5% | +$145K |
|
345
NXP Semiconductors
NXPI
$57.8B
| $23.7M | 0.05% |
323,995
+15,659
| +5% | +$1.24M |
|
346
Incyte
INCY
$24.2B
| $23.4M | 0.05% |
368,555
+1,006
| +0.3% | +$65.3K |
|
347
TE Connectivity
TEL
$59.6B
| $23.4M | 0.05% |
309,820
-8,802
| -3% | -$678K |
|
348
Zebra Technologies
ZBRA
$14B
| $23.4M | 0.05% |
147,147
+39,448
| +37% | +$6.57M |
|
349
D.R. Horton
DHI
$40B
| $23.4M | 0.05% |
674,256
-34,974
| -5% | -$1.28M |
|
350
NNN REIT
NNN
$9.04B
| $23.3M | 0.05% |
479,682
+147,640
| +44% | +$7.04M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.